All Stories

  1. Fearnley, Lyle. Virulent zones: animal disease and global health at China's pandemic epicenter. 288 pp., illus., bibliogr. Durham, N.C.: Duke Univ. Press, 2020. £20.99 (paper)Keck, Frédéric. Avian reservoirs: virus hunters and birdwatchers in Chinese s...
  2. ​Disease X and Africa: How a Scientific Metaphor Entered Popular Imaginaries of the Online Public During the COVID-19 Pandemic
  3. Vaccine anxieties, vaccine preparedness: Perspectives from Africa in a Covid-19 era
  4. Engaging the Arts for Wellbeing in the United States of America: A Scoping Review
  5. Negotiating Intersecting Precarities: COVID-19, Pandemic Preparedness and Response in Africa
  6. Recognising Italy's mistakes in the public health response to COVID-19
  7. ‘…but not gagged’: Responding to Covid‐19 and its control measures in France, Italy and the USA
  8. When the pharmaceutical system creates persistent attachments or new appropriations of drug molecules
  9. When the pharmaceutical system creates persistent attachments or new appropriations of drug molecules
  10. Systematic Review of Arts-Based Interventions to Address Suicide Prevention and Survivorship in Australia, Canada, the United Kingdom, and the United States of America
  11. No country for young girls?
  12. Health Communication and the Arts in the United States: A Scoping Review
  13. ‘They’ll inject you and you’ll die’: from medication non-compliance to acceptance in Guinea’s Ebola treatment units
  14. Mobilising experience from Ebola to address plague in Madagascar and future epidemics
  15. Engaging conceptions of identity in a context of medical pluralism: explaining treatment choices for everyday illness in Niger
  16. A medicine for every sickness
  17. Medical Anthropology in Global Africa. Kathryn A. Rhine, John M. Janzen, Glenn Adams, and Heather Aldersey, eds. Lawrence: University of Kansas Publications in Anthropology, 2014, 169 pp.
  18. Prevention of mother-to-child HIV transmission in resource-limited settings: assessment of 99 Viramune Donation Programmes in 34 countries, 2000–2011
  19. Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries